Stock Scorecard
Stock Summary for Arcellx Inc (ACLX) - $58.25 as of 5/13/2025 8:11:12 PM EST
Total Score
8 out of 30
Safety Score
30 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ACLX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ACLX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ACLX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ACLX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ACLX (30 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 1 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ACLX
Financial Details for ACLX
Company Overview |
|
|---|---|
| Ticker | ACLX |
| Company Name | Arcellx Inc |
| Country | USA |
| Description | Arcellx, Inc., a clinical-stage biotechnology company, is engaged in the development of various immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland. |
| Sector Name | LIFE SCIENCES |
| Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 58.25 |
| Price 4 Years Ago | 0.00 |
| Last Day Price Updated | 5/13/2025 8:11:12 PM EST |
| Last Day Volume | 743,119 |
| Average Daily Volume | 813,387 |
| 52-Week High | 107.37 |
| 52-Week Low | 47.86 |
| Last Price to 52 Week Low | 21.71% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 69.96 |
| Sector PE | 49.22 |
| 5-Year Average PE | -34.99 |
| Free Cash Flow Ratio | 39.63 |
| Industry Free Cash Flow Ratio | 18.91 |
| Sector Free Cash Flow Ratio | 31.82 |
| Current Ratio Most Recent Quarter | 4.93 |
| Total Cash Per Share | 1.47 |
| Book Value Per Share Most Recent Quarter | 7.57 |
| Price to Book Ratio | 6.41 |
| Industry Price to Book Ratio | 9.00 |
| Sector Price to Book Ratio | 30.58 |
| Price to Sales Ratio Twelve Trailing Months | 42.69 |
| Industry Price to Sales Ratio Twelve Trailing Months | 43.08 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.54 |
| Analyst Buy Ratings | 12 |
| Analyst Strong Buy Ratings | 6 |
Share Statistics |
|
| Total Shares Outstanding | 55,107,000 |
| Market Capitalization | 3,209,982,750 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -51.86% |
| Reported EPS 12 Trailing Months | -2.99 |
| Reported EPS Past Year | -1.13 |
| Reported EPS Prior Year | -2.00 |
| Net Income Twelve Trailing Months | -162,420,000 |
| Net Income Past Year | -107,348,000 |
| Net Income Prior Year | -70,690,000 |
| Quarterly Revenue Growth YOY | -79.30% |
| 5-Year Revenue Growth | 493.45% |
| Operating Margin Twelve Trailing Months | -848.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 80,861,000 |
| Total Cash Past Year | 105,679,000 |
| Total Cash Prior Year | 394,583,000 |
| Net Cash Position Most Recent Quarter | 80,861,000 |
| Net Cash Position Past Year | 105,679,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 454,792,000 |
| Total Stockholder Equity Prior Year | 485,380,000 |
| Total Stockholder Equity Most Recent Quarter | 416,906,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -122,487,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -2.22 |
| Free Cash Flow Past Year | -96,901,000 |
| Free Cash Flow Prior Year | 186,145,000 |
Options |
|
| Put/Call Ratio | 1.93 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.46 |
| MACD Signal | -0.89 |
| 20-Day Bollinger Lower Band | 55.55 |
| 20-Day Bollinger Middle Band | 65.62 |
| 20-Day Bollinger Upper Band | 75.69 |
| Beta | 0.34 |
| RSI | 46.10 |
| 50-Day SMA | 70.47 |
| 150-Day SMA | 48.62 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 5/13/2025 4:25:06 PM EST |